ApoB: the lipid number that counts the particles, not the cholesterol

Before you read onResearch and educational information for adults, not medical advice. This entry explains one longevity term — what it means, why it matters and what the evidence says — and nothing here diagnoses, treats, cures or prevents any condition. Baseline labs come before anything, and your own physician has the final word. Longevity Bros offers coaching and written research protocols only — we do not sell, supply, source or ship any compound.

What it means

Apolipoprotein B is the structural protein on the surface of every atherogenic lipoprotein — LDL, VLDL, IDL and Lp(a). Each particle carries exactly one ApoB, so the blood concentration is a particle count. Atherosclerosis begins when these particles cross into the arterial wall and get retained, and the rate at which that happens depends on how many particles there are, not how much cholesterol each one carries.

LDL cholesterol and ApoB usually agree, but they diverge in the people who matter: those with insulin resistance or high triglycerides tend to have many small, cholesterol-poor particles — "normal" LDL-C, high ApoB.

Why it matters for longevity

Cardiovascular disease remains the leading cause of death and the main thief of healthspan, and ApoB-containing particles are its necessary cause. Lifetime exposure is cumulative, which is why lowering ApoB at 35 matters more than at 65 — and why "my cholesterol is fine" from a standard panel can be false reassurance.

What the evidence says

Mendelian randomisation studies (Ference 2017, 2019) show that genetic variants lowering ApoB lower cardiovascular risk in proportion to the ApoB change, regardless of which lipid the variant affects — the strongest causal evidence available in human medicine. In UK Biobank (Welsh 2019, 440,000 people) ApoB predicted heart attacks better than LDL-C or non-HDL-C, and once ApoB was known, LDL-C added nothing.

Trial data show the same: in statin and PCSK9-inhibitor trials, ApoB reduction tracks event reduction more closely than LDL-C reduction. Every major lipid guideline now lists ApoB as the preferred measure where available.

How to measure or use it

A standard immunoassay, no fasting needed, available on most lab menus for a few euros.
Population average is about 90–100 mg/dL (0.9–1.0 g/L). Guidelines treat under 80 mg/dL as desirable; many longevity physicians aim for under 60 mg/dL in people with other risk factors.
Levers in rough size: lipid-lowering drugs (statins, ezetimibe, PCSK9 inhibitors, bempedoic acid), then reduced saturated fat, more soluble fibre, weight loss and lower insulin resistance. Retest at 8–12 weeks after any change.

Biomarkers of ageing — ApoB in the core panel
Metabolic health — why insulin resistance raises particle count
Baseline labs — what to draw first

Frequently asked questions

What is a good ApoB level?

Under 80 mg/dL is the usual guideline target; under 60 mg/dL is often the aim with additional risk factors. Under 100 is average, not optimal.

Is ApoB better than LDL cholesterol?

Yes. It counts particles rather than cholesterol mass, predicts events better, and catches the high-particle, normal-LDL-C pattern that insulin resistance produces.

Can diet alone lower ApoB enough?

Typically by 10–20% through saturated-fat reduction, fibre and weight loss. Larger reductions usually need medication — a physician conversation.

Your own protocol

Want this applied to your own numbers?

Fifteen minutes of intake, your labs, a human-reviewed protocol within about 24 hours, three documents, a free coach call and check-ins through the cycle. €399, follow-up included.

Build my protocol Book a 15-minute call